International Pharmaceutical Law

The UK offers an unrivalled environment and opportunity for life sciences businesses around the world. Whether you are a UK business exporting or importing your products and services or an overseas business setting up or investing in the UK, we can offer you the specialist legal and practical support you need to succeed.

Pharmaceutical Industry Network Group

Our Pharmaceutical Industry Network Group (PING) is a diverse networking group, solely for people who are in the pharmaceutical supply chain with the main aim to discuss and share best practice, ideas and generally help each other in times of great change.

We hold an annual PING conference which includes guest speakers from across the sector discussing issues from changes in the NHS and UK legislation to Brexit and world-leading life sciences research and development opportunities.

Stay Up to Date With the Latest Guidance

We regularly provide guidance on the commercial issues affecting the sector in the UK, including the implications of Brexit. Read our guidance here.

Don't want to miss out on essential advice? Get the latest pharmaceutical law articles straight to your inbox by signing up to our Pharmaceuticals & Life Sciences Law Brief.

Subscribe Now

Examples of Our Work

International
- Acting for a trader client in legal proceedings concerning the parallel importation of a range of medical devices from continental Europe into the UK.
- Advising UK and overseas companies in the negotiation and drafting of various kinds of cross-border contracts in the life sciences sector including development, distribution, manufacture & supply and dossier licence agreements.
- Acting for a UK pharmaceutical company in the negotiation and drafting of a suite of agreements with an Indian pharmaceutical company. The agreements included a manufacture & supply agreement and a dossier licence and related to the launch of a range of pharmaceuticals in the UK.
- Acting on the acquisition of the Intellectual Property of a well-known OTC brand for a UK pharma company from its US owner.
- Acting on the potential sale to a US company of an Anglo-Indian company producing an innovative addiction-reduction product.
Contact us
National
- Providing advice in relation to medical device commercial feasibility studies for an international pharmaceutical company involving R&D, reimbursement and material transfer agreements.
- Negotiating and drafting non-commercial and investigator-led clinical trial agreements for a well-known cancer research charity, including providing general contract advice and drafting in relation to laboratory agreements and research collaborations for Phase II, III and IV clinical trials.
- Advising brand owners and traders in the parallel trade of pharmaceuticals and medical devices - both strategically and in disputes. This work covers the BMS trade mark conditions, the Specific Mechanism and the general international exhaustion of IP rights.
- Acting for a UK pharmaceutical company on the acquisition of certain brands from Big Pharma.
- Acquiring the rights in a therapeutic remedy for a start-up UK company and negotiating on-going licensing arrangements.
Contact us

International Pharmaceutical Law

Paul Gershlick

Pharmaceuticals & Life Sciences

Paul Gershlick

Tom Cahill

John Zucker